---
title: "Gentian Diagnostics: Key information relating to the proposed cash dividend"
description: financials dividend
---

Moss, 12 February 2026

The Board of Directors of Gentian Diagnostics ASA proposes a dividend of NOK 0.60 per  
share, based on the company's financial statements for the financial year 2025,  
to the General Meeting.

Dividend amount:               0.60 per share  
Announced currency:        Norwegian krone (NOK)  
Last day including right:   5 May 2026  
Ex-date:                               6 May 2026  
Record date:                       7 May 2026  
Payment date:                    from 18 May 2026  
Date of approval:               5 May 2026

For further information, please contact:

Njaal Kind, CFO  
njaal.kind@gentian.no  
+47 919 06 525 (mobile)

This information is subject to the disclosure requirements pursuant to section 5  
-12 of the Norwegian Securities Trading Act.

### You may also read

[Jul 02, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-key-information-relating-to-the-proposed-cash-dividend#)

##### [Gentian Diagnostics: Invitation to presentation of second quarter results](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

[Jun 24, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-key-information-relating-to-the-proposed-cash-dividend#)

##### [ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

[May 29, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-key-information-relating-to-the-proposed-cash-dividend#)

##### [Mandatory notification of trade](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)